<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medecol</journal-id><journal-title-group><journal-title xml:lang="ru">Медицина и экология</journal-title><trans-title-group xml:lang="en"><trans-title>Medicine and ecology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-6045</issn><issn pub-type="epub">2305-6053</issn><publisher><publisher-name>Карагандинский медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.59598/ME-2305-6053-2025-117-4-153-161</article-id><article-id custom-type="elpub" pub-id-type="custom">medecol-1161</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРГАНИЗАЦИЯ И ЭКОНОМИКА ЗДРАВООХРАНЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORGANIZATION AND ECONOMICS OF HEALTH</subject></subj-group></article-categories><title-group><article-title>Достижимость критериев качества спирометрии ATS/ERS2019 в эпидемиологическом исследовании</article-title><trans-title-group xml:lang="en"><trans-title>Spirometry performance and quality criteria AS OF ATS/ERS2019 in an epidemiological study</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Винников</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vinnikov</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Денис Владимирович Винников</p><p>050040, г. Алматы, пр. Аль-Фараби, 71</p></bio><bio xml:lang="en"><p>Denis Vladimirovich Vinnikov</p><p>050040,  Almaty c., al-Farabi ave., 71</p></bio><email xlink:type="simple">denisvinnikov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Даирұлы</surname><given-names>Ж.</given-names></name><name name-style="western" xml:lang="en"><surname>Dairuly</surname><given-names>Zh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>050040, г. Алматы, пр. Аль-Фараби, 71</p></bio><bio xml:lang="en"><p>050040,  Almaty c., al-Farabi ave., 71</p></bio><email xlink:type="simple">info@kaznu.edu.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мукатова</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Mukatova</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>010000, г. Астана, ул. Бейбітшілік, 49А</p></bio><bio xml:lang="en"><p>010000, Astana c., Beibitshilik 49а</p></bio><email xlink:type="simple">mail@amu.kz</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Раушанова</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Raushanova</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>050040, г. Алматы, пр. Аль-Фараби, 71</p></bio><bio xml:lang="en"><p>050040,  Almaty c., al-Farabi ave., 71</p></bio><email xlink:type="simple">info@kaznu.edu.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Романова</surname><given-names>Ж. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Romanova</surname><given-names>Zh. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>050040, г. Алматы, пр. Аль-Фараби, 71</p></bio><bio xml:lang="en"><p>050040,  Almaty c., al-Farabi ave., 71</p></bio><email xlink:type="simple">info@kaznu.edu.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Турдалы</surname><given-names>Ф. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Turdaly</surname><given-names>F. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>160000, г. Шымкент, ул. Майлыкожа, 4</p></bio><bio xml:lang="en"><p>160000, Shymkent c., Mailykozha str.,4</p></bio><email xlink:type="simple">gkkp_okb@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кушекбаева</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Kushekbayeva</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>160019, г. Шымкент, пл. аль-Фараби,1</p></bio><bio xml:lang="en"><p>160019, Shymkent c., al-Farabi ave., 1</p></bio><email xlink:type="simple">info@skma.kz</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Казахский национальный университет им. аль-Фараби<country>Казахстан</country></aff><aff xml:lang="en">Al-Farabi Kazakh National University<country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">НАО «Медицинский университет Астана»<country>Казахстан</country></aff><aff xml:lang="en">Astana Medical University NC JSC<country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru">ГКП на ПХВ «Областная клиническая больница Туркестанской области»<country>Казахстан</country></aff><aff xml:lang="en">Regional Clinical Hospital of Turkestan region State-Owned Enterprise On The Right Of Economic Management<country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru">АО «Южно-Казахстанская медицинская академия»<country>Казахстан</country></aff><aff xml:lang="en">South-Kazakhstan Medical Academy<country>Kazakhstan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>23</day><month>01</month><year>2026</year></pub-date><volume>0</volume><issue>4</issue><fpage>153</fpage><lpage>161</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Винников Д.В., Даирұлы Ж., Мукатова И.Ю., Раушанова А.М., Романова Ж.В., Турдалы Ф.М., Кушекбаева А.Е., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Винников Д.В., Даирұлы Ж., Мукатова И.Ю., Раушанова А.М., Романова Ж.В., Турдалы Ф.М., Кушекбаева А.Е.</copyright-holder><copyright-holder xml:lang="en">Vinnikov D.V., Dairuly Z., Mukatova I.Y., Raushanova A.M., Romanova Z.V., Turdaly F.M., Kushekbayeva A.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://medecol.qmu.kz/jour/article/view/1161">https://medecol.qmu.kz/jour/article/view/1161</self-uri><abstract><sec><title>Цель</title><p>Цель. Оценка достижимости критериев качества спирометрии по протоколам ATS/ERS-2019 в рамках популяционного эпидемиологического исследования.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Спирометрия проведена у 989 взрослых (старше 18 лет, медиана возраста 42 (межквартильный интервал (МКИ) 25;55) года) жителей города Шымкент из числа общей популяции города после обучения. Качество выполнения оценивали по комплексу показателей, включая разницу по объему форсированного выдоха за первую секунду (ОФВ1) и форсированной жизненной емкости легких (ФЖЕЛ) между кривыми, в многофакторном регрессионном анализе оценивали предикторы достижения критериев.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. Общее число попыток варьировало от 3 до 23 (медиана 4, МКИ 3;6), и с ним независимо друг от друга были ассоциированы только возраст, ОФВ1%, статус курения и уровень образования. По показателю ΔОФВ1 медиана разницы составила 0,05 л (МКИ 0,03;0,09), по ΔФЖЕЛ – 0,06 (МКИ 0,03;0,1). Медиана объема обратной экстраполяции составила 0,07 (МКИ 0,05;0,11). Медиана скорости остановки выдоха (СОВ) составила 0,16 (МКИ 0,09;0,33) л, и показатель был независимо ассоциирован с возрастом, ОФВ1 и ФЖЕЛ, их отношением, а также с наличием ХОБЛ. Достичь целевого значения СОВ в 0,025 л/сек удалось достичь только у 13 (1%) пациентов из 989.</p></sec><sec><title>Выводы</title><p>Выводы. В целом достижение высокого качества выполнения спирометрии после обучения представляется возможным по большинству показателей, однако достижение рекомендуемой скорости остановки выдоха в 25 мл/с представляет собой наиболее трудную задачу.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To test the performance and assess the feasibility of spirometric quality criteria of ATS/ERS2019 protocol in an epidemiological study.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Spirometry was completed in 989 adults (18 years old and older, median age 42 (interquartile range (IQR) 25;55) years), residents of Shymkent selected from the general population after training. Spirometry quality was assessed with a range of criteria, including the difference in forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) between attempts, whereas the predictors of criteria attainment were tested in adjusted regression models.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. Total number of attempts varied from 3 to 23 (median 4, IQR 3;6) and it was independently associated with age, FEV1%, smoking status and educational level. ΔFEV1 median equaled 0.05 l (IQR 0.03;0.09), whereas ΔFVC median was 0.06 (IQR 0.03;0.10). Back extrapolation volume median was 0.07 (IQR 0.05;0.11). End-expiratory flow (EEF) median was 0.16 (IQR 0.09;0.33) l, and was independently associated with age, FEV1, FVC and their ratio, as well as diagnosed COPD. The target EEF value of 0.025 l/s could be attained in only 13 subjects (1%) out of 989.</p></sec><sec><title>Conclusions</title><p>Conclusions. Overall, high standard of spirometry could be attained with the majority of indicators after the relevant training; however, keeping the expiration till the target end-expiratory flow of 25 ml/s is the greatest challenge and hard to achieve.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>спирометрия</kwd><kwd>форсированный маневр</kwd><kwd>обструкция</kwd><kwd>популяционные исследования</kwd><kwd>пульмонология</kwd></kwd-group><kwd-group xml:lang="en"><kwd>spirometry</kwd><kwd>forced maneuver</kwd><kwd>obstruction</kwd><kwd>population-based studies</kwd><kwd>pulmonology</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Работа выполнена в рамках проекта грантового финансирования Министерства науки и высшего образования (грант АР23484384)</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Chen S., Kuhn M., Prettner K., Yu F., Yang T., Bärnighausen T., Bloom D.E., Wang C. The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study. Lancet Glob Health. 2023; 11 (8): e1183-e1193. https://doi.org/10.1016/S2214-109X(23)00217-6</mixed-citation><mixed-citation xml:lang="en">Chen S., Kuhn M., Prettner K., Yu F., Yang T., Bärnighausen T., Bloom D.E., Wang C. The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study. Lancet Glob Health. 2023; 11 (8): e1183-e1193. https://doi.org/10.1016/S2214-109X(23)00217-6</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Culver B.H., Graham B.L., Coates A.L., Wanger J., Berry C.E., Clarke P.K., Hallstrand T.S., Hankinson J.L., Kaminsky D.A., MacIntyre N.R., McCormack M.C., Rosenfeld M., Stanojevic S., Weiner D.J.; ATS Committee on Proficiency Standards for Pulmonary Function Laboratories. Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. Am. J. Respir. Crit. Care Med. 2017; 196 (11): 1463-1472. https://doi.org/10.1164/rccm.201710-1981ST</mixed-citation><mixed-citation xml:lang="en">Culver B.H., Graham B.L., Coates A.L., Wanger J., Berry C.E., Clarke P.K., Hallstrand T.S., Hankinson J.L., Kaminsky D.A., MacIntyre N.R., McCormack M.C., Rosenfeld M., Stanojevic S., Weiner D.J.; ATS Committee on Proficiency Standards for Pulmonary Function Laboratories. Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. Am. J. Respir. Crit. Care Med. 2017; 196 (11): 1463-1472. https://doi.org/10.1164/rccm.201710-1981ST</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Diab N., Gershon A.S., Sin D.D., Tan W.C., Bourbeau J., Boulet L.P., Aaron S.D. Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 2018; 198 (9): 1130-1139. https://doi.org/10.1164/rccm.201804-0621CI</mixed-citation><mixed-citation xml:lang="en">Diab N., Gershon A.S., Sin D.D., Tan W.C., Bourbeau J., Boulet L.P., Aaron S.D. Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 2018; 198 (9): 1130-1139. https://doi.org/10.1164/rccm.201804-0621CI</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Enright P.L., Skloot G.S., Cox-Ganser J.M., Udasin I.G., Herbert R. Quality of spirometry performed by 13,599 participants in the World Trade Center Worker and Volunteer Medical Screening Program. Respir Care. 2010; 55 (3): 303- 309.</mixed-citation><mixed-citation xml:lang="en">Enright P.L., Skloot G.S., Cox-Ganser J.M., Udasin I.G., Herbert R. Quality of spirometry performed by 13,599 participants in the World Trade Center Worker and Volunteer Medical Screening Program. Respir Care. 2010; 55 (3): 303-309.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Fortis S., Georgopoulos D., Tzanakis N., Sciurba F., Zabner J., Comellas A.P. Chronic obstructive pulmonary disease (COPD) and COPD-like phenotypes. Front Med (Lausanne). 2024; 11: 1375457. https://doi.org/10.3389/fmed.2024.1375457</mixed-citation><mixed-citation xml:lang="en">Fortis S., Georgopoulos D., Tzanakis N., Sciurba F., Zabner J., Comellas A.P. Chronic obstructive pulmonary disease (COPD) and COPD-like phenotypes. Front Med (Lausanne). 2024; 11: 1375457. https://doi.org/10.3389/fmed.2024.1375457</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Graham B.L., Steenbruggen I., Miller M.R., Barjaktarevic I.Z., Cooper B.G., Hall G.L., Hallstrand T.S., Kaminsky D.A., McCarthy K., McCormack M.C., Oropez C.E., Rosenfeld M., Stanojevic S., Swanney M.P., Thompson B.R. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am. J. Respir. Crit. Care Med. 2019; 200 (8): e70-e88. https://doi.org/10.1164/rccm.201908-1590ST</mixed-citation><mixed-citation xml:lang="en">Graham B.L., Steenbruggen I., Miller M.R., Barjaktarevic I.Z., Cooper B.G., Hall G.L., Hallstrand T.S., Kaminsky D.A., McCarthy K., McCormack M.C., Oropez C.E., Rosenfeld M., Stanojevic S., Swanney M.P., Thompson B.R. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am. J. Respir. Crit. Care Med. 2019; 200 (8): e70-e88. https://doi.org/10.1164/rccm.201908-1590ST</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hegewald M.J., Gallo H.M., Wilson E.L. Accuracy and Quality of Spirometry in Primary Care Offices. Ann. Am. Thorac. Soc. 2016; 13 (12): 2119-2124. https://doi.org/10.1513/AnnalsATS.201605-418OC</mixed-citation><mixed-citation xml:lang="en">Hegewald M.J., Gallo H.M., Wilson E.L. Accuracy and Quality of Spirometry in Primary Care Offices. Ann. Am. Thorac. Soc. 2016; 13 (12): 2119-2124. https://doi.org/10.1513/AnnalsATS.201605-418OC</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Janssens W., Liu Y., Liu D., Kesten S., Tashkin D.P., Celli B.R., Decramer M. Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT®). Respir. Med. 2013; 107 (9): 1409-1416. https://doi.org/10.1016/j.rmed.2013.04.0159</mixed-citation><mixed-citation xml:lang="en">Janssens W., Liu Y., Liu D., Kesten S., Tashkin D.P., Celli B.R., Decramer M. Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT®). Respir. Med. 2013; 107 (9): 1409-1416. https://doi.org/10.1016/j.rmed.2013.04.0159</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lopes A.J. Advances in spirometry testing for lung function analysis. Expert Rev. Respir. Med. 2019; 13 (6): 559-569. https://doi.org/10.1080/17476348.2019.1607301</mixed-citation><mixed-citation xml:lang="en">Lopes A.J. Advances in spirometry testing for lung function analysis. Expert Rev. Respir. Med. 2019; 13 (6): 559-569. https://doi.org/10.1080/17476348.2019.1607301</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Quanjer P.H., Brazzale D.J., Boros P.W., Pretto J.J. Implications of adopting the Global Lungs Initiative 2012 all-age reference equations for spirometry. Eur. Respir. J. 2013; 42 (4): 1046-1054. https://doi.org/10.1183/09031936.00195512</mixed-citation><mixed-citation xml:lang="en">Quanjer P.H., Brazzale D.J., Boros P.W., Pretto J.J. Implications of adopting the Global Lungs Initiative 2012 all-age reference equations for spirometry. Eur. Respir. J. 2013; 42 (4): 1046-1054. https://doi.org/10.1183/09031936.00195512</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Quanjer P.H., Stanojevic S., Cole T.J., Baur X., Hall G.L., Culver B.H. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. European Respiratory Journal. 2012; 40: 1324-1343.</mixed-citation><mixed-citation xml:lang="en">Quanjer P.H., Stanojevic S., Cole T.J., Baur X., Hall G.L., Culver B.H. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. European Respiratory Journal. 2012; 40: 1324-1343.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ruvuna L., Sood A. Epidemiology of Chronic Obstructive Pulmonary Disease. Clin. Chest. Med. 2020; 41 (3): 315-327. https://doi.org/10.1016/j.ccm.2020.05.002</mixed-citation><mixed-citation xml:lang="en">Ruvuna L., Sood A. Epidemiology of Chronic Obstructive Pulmonary Disease. Clin. Chest. Med. 2020; 41 (3): 315-327. https://doi.org/10.1016/j.ccm.2020.05.002</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ryu J.Y., Sunwoo Y.E., Lee S.Y., Lee C.K., Kim J.H., Lee J.T., Kim D.H. Chronic Obstructive Pulmonary Disease (COPD) and Vapors, Gases, Dusts, or Fumes (VGDF): A Meta-analysis. COPD. 2015; 12 (4): 374-380. https://doi.org/10.3109/15412555.2014.949000</mixed-citation><mixed-citation xml:lang="en">Ryu J.Y., Sunwoo Y.E., Lee S.Y., Lee C.K., Kim J.H., Lee J.T., Kim D.H. Chronic Obstructive Pulmonary Disease (COPD) and Vapors, Gases, Dusts, or Fumes (VGDF): A Meta-analysis. COPD. 2015; 12 (4): 374-380. https://doi.org/10.3109/15412555.2014.949000</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Safiri S., Carson-Chahhoud K., Noori M., Nejadghaderi S.A., Sullman M.J.M., Ahmadian Heris J., Ansarin K., Mansournia M.A., Collins G.S., Kolahi A.A., Kaufman J.S. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ. 2022; 378: e069679. https://doi.org/10.1136/bmj-2021-069679</mixed-citation><mixed-citation xml:lang="en">Safiri S., Carson-Chahhoud K., Noori M., Nejadghaderi S.A., Sullman M.J.M., Ahmadian Heris J., Ansarin K., Mansournia M.A., Collins G.S., Kolahi A.A., Kaufman J.S. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ. 2022; 378: e069679. https://doi.org/10.1136/bmj-2021-069679</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Singh D., Agusti A., Anzueto A., Barnes P.J., Bourbeau J., Celli B.R., Criner G.J., Frith P., Halpin D.M.G., Han M., López Varela M.V., Martinez F., Montes de Oca M., Papi A., Pavord I.D., Roche N., Sin D.D., Stockley R., Vestbo J., Wedzicha J.A., Vogelmeier C. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur. Respir. J. 2019; 53 (5): 1900164. https://doi.org/10.1183/13993003.00164-2019</mixed-citation><mixed-citation xml:lang="en">Singh D., Agusti A., Anzueto A., Barnes P.J., Bourbeau J., Celli B.R., Criner G.J., Frith P., Halpin D.M.G., Han M., López Varela M.V., Martinez F., Montes de Oca M., Papi A., Pavord I.D., Roche N., Sin D.D., Stockley R., Vestbo J., Wedzicha J.A., Vogelmeier C. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur. Respir. J. 2019; 53 (5): 1900164. https://doi.org/10.1183/13993003.00164-2019</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Stanojevic S., Kaminsky D.A., Miller M.R., Thompson B., Aliverti A., Barjaktarevic I., Cooper B.G., Culver B., Derom E., Hall G.L., Hallstrand T.S., Leuppi J.D., MacIntyre N., McCormack M., Rosenfeld M., Swenson E.R. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur. Respir. J. 2022; 60 (1): 2101499. https://doi.org/10.1183/13993003.01499-2021</mixed-citation><mixed-citation xml:lang="en">Stanojevic S., Kaminsky D.A., Miller M.R., Thompson B., Aliverti A., Barjaktarevic I., Cooper B.G., Culver B., Derom E., Hall G.L., Hallstrand T.S., Leuppi J.D., MacIntyre N., McCormack M., Rosenfeld M., Swenson E.R. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur. Respir. J. 2022; 60 (1): 2101499. https://doi.org/10.1183/13993003.01499-2021</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Vinnikov D., Raushanova A., Kyzayeva A., Romanova Z., Tulekov Z., Kenessary D., Auyezova A. Lifetime Occupational History, Respiratory Symptoms and Chronic Obstructive Pulmonary Disease: Results from a Population-Based Study. Int. J. Chron. Obstruct. Pulmon. Dis. 2019; 14: 3025-3034. https://doi.org/10.2147/COPD.S229119</mixed-citation><mixed-citation xml:lang="en">Vinnikov D., Raushanova A., Kyzayeva A., Romanova Z., Tulekov Z., Kenessary D., Auyezova A. Lifetime Occupational History, Respiratory Symptoms and Chronic Obstructive Pulmonary Disease: Results from a Population-Based Study. Int. J. Chron. Obstruct. Pulmon. Dis. 2019; 14: 3025- 3034. https://doi.org/10.2147/COPD.S229119</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
